A group O RhD-negative pregnant patient with anti-D antibody at titer 1:2048 delivered a baby boy by cesarean section at 38 + 6 weeks gestational age. The neonate typed as group O, but D antigen was at first uncertain. DAT and antibody screen of newborn were both positive. Various assays were used for D antigen determination. Ultimately, D antigen blocked by high-titer maternal anti-D antibody was confirmed. Total bilirubin of the newborn was 52.7 umol/L, and hemoglobin was 1.46 mg/ dL. O RhD-negative red cells were used for an exchange transfusion.
ABO and Rh blood group systems are the most important red blood cell antigens, both for transfusion and for their association with hemolytic disease of the fetus and newborn (HDFN). Immune anti-D antibody can shield the D antigen on red cells, requiring a variety of test methods and serological tests to unblock and detect it. This unusual situation requires experienced blood bank testing staff to first suspect the blocking phenomenon and then confirm it.
Here, we report a case of blocked D in the clinical context of RhD-HDFN due to high-titer maternal anti-D antibody.
Case Presentation
A 24-year-old patient was transferred from a local hospital to our center at 38 + 4 gestational weeks (G2P0 + 1) due to antibody screen positivity. We typed the patient as O RhD Abbreviations DAT, direct antihuman globulin test; HDFN, hemolytic disease of the fetus and newborn; TB, total bilirubin; Hb, hemoglobin; RT, room time.
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negative and found anti-D antibody at 1:2048 titer. Transfusion history and RhD immunoblobulin injection were denied.
The male newborn was delivered at 38 + 6 weeks by cesarean section. Total bilirubin (TB) was 52.7 umol/L (reference range: 2-210 umol/L) with hemoglobin (Hb) 1.46 mg/dL (reference range: 1.70-2.10 mg/dL). ABO blood grouping showed O, but RhD antigen was uncertain at first. O RhDnegative red cells were used for exchange transfusion. TB rose to 105.7 umol/L after exchange transfusion, and then gradually decreased to normal range. TB was 48 umol/L and Hb 1.03 mg/dL when the baby was discharged, but his parents refused transfusion to improve anemia. The baby was readmitted after 11 days due to falling hemoglobin to 0.78 mg/dL. O RhD-negative red cells were again transfused, after which Hb went up to 1.51 mg/dL then discharged.
Results

Serological Results
ABO type of the newborn tested by automated system (ORTHO AutoVue Innova, Ortho Clinical Diagnostics, Raritan, NJ) was group O, but anti-D and control column were all positive (4+). When the same sample was used to test for HDFN by day staff, D antigen was negative by concave glass plate (monoclonal anti-D IgM). Supplemental tests were then done. Blood group identification by automated gel card system (Wadiana, Grifols, Barcelona, Spain) and saline tube method confirmed O group, but D antigen and control column were negative by the Grifols system. Tube method showed weak positive D antigen at room temperature; in order to prolong reaction time, tubes were centrifuged again after 10 minutes at room temperature, but reactivity strength did not change significantly. When test tubes were incubated at 4°C for 10 min, D antigen showed 1+ reactivity. Next a heat elution was performed at 45°C. After elution, D antigen was retested by the above methods. The Grifols card now showed 2+ D positivity; the ORTHO card still showed 4+ both for anti-D and control column. Saline tube method now showed 3+ positivity. Detailed information is shown in Table 1 . RhD genotyping later corroborated the positive D antigen of the newborn (RhD/-). The blocked D phenomenon due to maternal anti-D is well recognized but not very common. 3, 4 Serologic testing has long been the standard method for typing red cell antigens in blood banks. Manual tube-based typing was long the most prevalent primary testing method. It was not well suited to high-volume facilities and could not easily be automated. For those reasons gel typing and microplate typing methods have increased in popularity. 5 Vendors and blood bank laboratories must establish interpretation standards appropriate to each method's serological reactivity patterns and range of reaction strength.
Hemolytic Disease Testing
Different typing methods may be used when red cell antigen typing is inconclusive or yields unexpected results. This is very important for resolving a suspected incorrect antigen typing result such as weak reactivity on serological D typing (1+/2+ or different from established standard). In our blood bank, blood specimen of this newborn was initially typed by the ORTHO AutoVue Innova System. The D antigen showed 4+, but control column was also 4+, which was a combination of findings that cannot be accepted. When coupled with information that DAT was 4+ and 3-cell antibody screen was strongly positive, we could not ascertain whether the baby was D positive or false positive due to interference by strongly positive DAT. With the above in mind, gel typing by the Grifols Wadiana Compact and tube typing was added. Negative reaction (Grifols method) and weak reaction (tube method) were shown for D antigen. Because the mother was D negative with high titer (1:2048) anti-D antibody, we speculated that D antigen may be 
Conclusion
Sometimes a blood sample from a newborn will be received prior to receipt of a maternal sample or serologic information about the maternal sample. When D antigen of a newborn with high bilirubin and low hemoglobin is negative or only weak reactive, yet DAT or antibody screening is positive, blocked D phenomenon should be considered 
